The percentage of T cells expressing CD4+CD25+ and CD4+CD45RO+ was significantly higher, while the percentage of T cells expressing CD4+CC chemokine receptor (CCR)3+ (Th2 cells) was significantly lower in MS patients than in HC. The gene discussed is CD4; the disease is myeloid sarcoma.